Dapagliflozin (10 mg) + Glimepiride (1 mg) + Metformin (500 mg) ER is a triple-action, prescription oral combination medication used to manage Type 2 Diabetes Mellitus in adults when diet, exercise, and dual therapy fail. It works by increasing glucose excretion through urine (dapagliflozin), stimulating insulin release (glimepiride), and enhancing insulin sensitivity (metformin) to improve glycemic control.
